阿尔茨海默病的性别差异。
Sex Differences in Alzheimer's Disease.
机构信息
Department of Neurological Sciences, Rush Alzheimer's Disease Center, Rush University Medical Center, 1750 West Harrison Street, Suite 1000, Chicago, IL 60612, USA.
Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
出版信息
Neurol Clin. 2023 May;41(2):343-358. doi: 10.1016/j.ncl.2023.01.001.
Abstract
Reviewing the research presented in this article, it is evident that from an epidemiological perspective, it is important to evaluate the extent to which findings of sex and gender differences in Alzheimer's dementia (AD) are due to differences in longevity, survival bias, and comorbidities. Medical, genetic, psychosocial, and behavioral factors, in addition to hormonal factors, can differentially affect the risk and progression of AD in women versus men. Further, evaluation of sex differences in AD progression and the trajectory of change in cognitive function, neuroimaging, cerebrospinal fluid (CSF), and blood-based biomarkers of AD is needed. Finally, identifying sex differences in AD biomarkers and change across the lifespan is critical for the planning of prevention trials to reduce the risk of developing AD.
摘要
回顾本文所呈现的研究，从流行病学的角度来看，评估阿尔茨海默病（AD）中性别差异的研究结果在多大程度上归因于寿命、生存偏差和合并症的差异是很重要的。除了激素因素外，医学、遗传、心理社会和行为因素也会对女性和男性 AD 的风险和进展产生不同的影响。此外，还需要评估 AD 进展和认知功能、神经影像学、脑脊液（CSF）和 AD 血液生物标志物变化轨迹方面的性别差异。最后，确定 AD 生物标志物和整个生命周期变化中的性别差异对于预防试验的规划以降低 AD 的发病风险至关重要。
相似文献
1
Sex Differences in Alzheimer's Disease.阿尔茨海默病的性别差异。
Neurol Clin. 2023 May;41(2):343-358. doi: 10.1016/j.ncl.2023.01.001.
2
Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.血浆 p-tau181 与阿尔茨海默病生物标志物、认知衰退和临床进展的性别差异。
Mol Psychiatry. 2022 Oct;27(10):4314-4322. doi: 10.1038/s41380-022-01675-8. Epub 2022 Jun 29.
3
Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.阿尔茨海默病的性别差异：血浆 MMP-9 和疾病严重程度标志物。
Alzheimers Res Ther. 2022 Nov 2;14(1):160. doi: 10.1186/s13195-022-01106-4.
4
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化：两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
5
Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.神经心理学衰退可改善痴呆症的预测，超越阿尔茨海默病生物标志物和轻度认知障碍诊断。
J Alzheimers Dis. 2019;69(4):1171-1182. doi: 10.3233/JAD-180525.
6
Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial.阿尔茨海默病的研究诊断标准：来自 LipiDiDiet 随机对照试验的结果。
Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3.
7
Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.NIA-AA 研究框架的应用：在 AIBL 研究中使用脑脊液生物标志物来定义阿尔茨海默病的生物学定义。
J Prev Alzheimers Dis. 2019;6(4):248-255. doi: 10.14283/jpad.2019.25.
8
Association between Longitudinal Cerebrospinal Fluid Alzheimer's Biomarkers and the Lifestyle for Brain Health (LIBRA) Index: Findings from the European Prevention of Alzheimer's Dementia Cohort Study (EPAD LCS).纵向脑脊液阿尔茨海默病生物标志物与大脑健康生活方式（LIBRA）指数之间的关联：来自欧洲预防阿尔茨海默病痴呆症队列研究（EPAD LCS）的结果。
J Prev Alzheimers Dis. 2023;10(3):543-550. doi: 10.14283/jpad.2023.31.
9
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.生物标志物组合对预测轻度认知障碍向阿尔茨海默病痴呆进展的增量价值。
Alzheimers Res Ther. 2017 Oct 10;9(1):84. doi: 10.1186/s13195-017-0301-7.
10
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease.与脑脊液磷酸化 tau 水平相关的 SNPs 影响阿尔茨海默病的下降速度。
PLoS Genet. 2010 Sep 16;6(9):e1001101. doi: 10.1371/journal.pgen.1001101.
引用本文的文献
1
DTI versus NODDI White Matter Microstructural Biomarkers of Alzheimer's Disease.阿尔茨海默病的弥散张量成像（DTI）与神经突方向离散与密度成像（NODDI）白质微观结构生物标志物
bioRxiv. 2025 Aug 28:2025.08.22.671829. doi: 10.1101/2025.08.22.671829.
2
Cerebral blood flow in elastin haploinsufficient and 3xTg-AD mice.弹性蛋白单倍不足和3xTg-AD小鼠的脑血流量
bioRxiv. 2025 Aug 22:2025.08.18.670895. doi: 10.1101/2025.08.18.670895.
3
Sex differences in clinical risk factors for Alzheimer's dementia patients with early-onset and late-onset.早发型和晚发型阿尔茨海默病痴呆患者临床危险因素的性别差异。
Front Glob Womens Health. 2025 Aug 4;6:1601375. doi: 10.3389/fgwh.2025.1601375. eCollection 2025.
4
Cystatin F-a key player in central nervous system disease.胱抑素F——中枢神经系统疾病的关键因素。
J Neuroinflammation. 2025 Aug 14;22(1):203. doi: 10.1186/s12974-025-03526-z.
5
X chromosome-wide association studies in neurological disorders: uncovering the hidden influence of the X chromosome.神经系统疾病中的X染色体全基因组关联研究：揭示X染色体的潜在影响
Front Genet. 2025 Jul 30;16:1650259. doi: 10.3389/fgene.2025.1650259. eCollection 2025.
6
Special Issue: "New Trends in Alzheimer's Disease Research: From Molecular Mechanisms to Therapeutics: 2nd Edition".特刊：“阿尔茨海默病研究新趋势：从分子机制到治疗方法：第2版”
Int J Mol Sci. 2025 Jul 25;26(15):7175. doi: 10.3390/ijms26157175.
7
Trends in the Prevalence and Development of Alzheimer's Disease Among the Elderly Chinese Population: A Systematic Review.中国老年人群中阿尔茨海默病的患病率及发展趋势：一项系统综述
Rev Neurol. 2025 Jul 28;80(6):36394. doi: 10.31083/RN36394.
8
Unveiling the role of erinacines in the neuroprotective effects of : a systematic review in preclinical models.揭示齿孔酸在[具体事物]神经保护作用中的角色：临床前模型的系统评价
Front Pharmacol. 2025 Jun 23;16:1582081. doi: 10.3389/fphar.2025.1582081. eCollection 2025.
9
Withaferin A Rescues Brain Network Dysfunction and Cognitive Deficits in a Mouse Model of Alzheimer's Disease.Withaferin A可挽救阿尔茨海默病小鼠模型中的脑网络功能障碍和认知缺陷。
Pharmaceuticals (Basel). 2025 May 29;18(6):816. doi: 10.3390/ph18060816.
10
Right hemisphere engagement in language abilities in older adults: indication of compensation rather than decline.老年人语言能力中的右脑参与：补偿而非衰退的迹象。
Front Aging. 2025 Jun 2;6:1458692. doi: 10.3389/fragi.2025.1458692. eCollection 2025.
本文引用的文献
1
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.阿尔茨海默病协会关于阿尔茨海默病血液生物标志物的合理使用建议。
Alzheimers Dement. 2022 Dec;18(12):2669-2686. doi: 10.1002/alz.12756. Epub 2022 Jul 31.
2
Aducanumab: Appropriate Use Recommendations Update.阿杜卡奴单抗：合理使用建议更新。
J Prev Alzheimers Dis. 2022;9(2):221-230. doi: 10.14283/jpad.2022.34.
3
Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy.阿尔茨海默病患者接受抗β淀粉样蛋白治疗后的淀粉样相关成像异常的检测与管理。
J Prev Alzheimers Dis. 2022;9(2):211-220. doi: 10.14283/jpad.2022.21.
4
Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysis.阿尔茨海默病痴呆症中神经精神症状的性别差异：荟萃分析。
Alzheimers Res Ther. 2022 Apr 4;14(1):48. doi: 10.1186/s13195-022-00991-z.
5
Sex Differences in the Association Between Midlife Cardiovascular Conditions or Risk Factors With Midlife Cognitive Decline.中年心血管疾病或危险因素与中年认知能力下降之间的性别差异。
Neurology. 2022 Feb 8;98(6):e623-e632. doi: 10.1212/WNL.0000000000013174. Epub 2022 Jan 5.
6
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.用于阿尔茨海默病的血液生物标志物：迈向临床应用
Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.
7
Late-Life Depression, Cognitive Impairment, and Relationship with Alzheimer's Disease.老年期抑郁症、认知障碍与阿尔茨海默病的关系。
Dement Geriatr Cogn Disord. 2021;50(5):414-424. doi: 10.1159/000519453. Epub 2021 Nov 25.
8
Association of Premenopausal Bilateral Oophorectomy With Cognitive Performance and Risk of Mild Cognitive Impairment.绝经前双侧卵巢切除术与认知表现和轻度认知障碍风险的关联。
JAMA Netw Open. 2021 Nov 1;4(11):e2131448. doi: 10.1001/jamanetworkopen.2021.31448.
9
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis.阿尔茨海默病临床试验中女性比例和按性别报告结局的情况：系统评价和荟萃分析。
JAMA Netw Open. 2021 Sep 1;4(9):e2124124. doi: 10.1001/jamanetworkopen.2021.24124.
10
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.一项针对 1126563 人的全基因组关联研究确定了阿尔茨海默病的新风险基因座。
Nat Genet. 2021 Sep;53(9):1276-1282. doi: 10.1038/s41588-021-00921-z. Epub 2021 Sep 7.
Zotero 插件